- Home
- FHN vs RGEN Comparison
FHN vs RGEN Comparison
Compare FHN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHN
- RGEN
- Stock Information
- Founded
- FHN 1864
- RGEN 1981
- Country
- FHN United States
- RGEN United States
- Employees
- FHN N/A
- RGEN N/A
- Industry
- FHN Major Banks
- RGEN Medical/Dental Instruments
- Sector
- FHN Finance
- RGEN Health Care
- Exchange
- FHN Nasdaq
- RGEN Nasdaq
- Market Cap
- FHN 8.5B
- RGEN 8.2B
- IPO Year
- FHN N/A
- RGEN N/A
- Fundamental
- Price
- FHN $15.74
- RGEN $136.22
- Analyst Decision
- FHN Buy
- RGEN Buy
- Analyst Count
- FHN 13
- RGEN 10
- Target Price
- FHN $17.38
- RGEN $188.38
- AVG Volume (30 Days)
- FHN 4.1M
- RGEN 772.8K
- Earning Date
- FHN 10-16-2024
- RGEN 10-29-2024
- Dividend Yield
- FHN 3.79%
- RGEN N/A
- EPS Growth
- FHN N/A
- RGEN N/A
- EPS
- FHN 1.21
- RGEN N/A
- Revenue
- FHN $2,947,000,000.00
- RGEN $602,354,000.00
- Revenue This Year
- FHN N/A
- RGEN $0.08
- Revenue Next Year
- FHN $3.34
- RGEN $12.97
- P/E Ratio
- FHN $13.07
- RGEN N/A
- Revenue Growth
- FHN N/A
- RGEN N/A
- 52 Week Low
- FHN $10.08
- RGEN $110.45
- 52 Week High
- FHN $17.46
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- FHN 48.82
- RGEN 37.10
- Support Level
- FHN $14.90
- RGEN $138.80
- Resistance Level
- FHN $16.76
- RGEN $150.72
- Average True Range (ATR)
- FHN 0.40
- RGEN 5.27
- MACD
- FHN -0.03
- RGEN -1.23
- Stochastic Oscillator
- FHN 48.55
- RGEN 1.94
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The regional bank is responsible for roughly 65% of its revenue, while capital markets make a 25% contribution. The remainder is split between the firm's non-strategic (wind-down) and corporate operations. First Horizon concentrates on offering a variety of banking products mainly in its home state, where it has the second- largest deposit franchise with a 13% deposit market share.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.